[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-368297-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-368297-en":131},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","new-insights-on-anti-tumor-immunity-of-cd8-t-cells-cancer-stem-cells-tumor-immune-microenvironment-and-immunotherapy","New insights on anti-tumor immunity of CD8+ T cells: cancer stem cells, tumor immune microenvironment and immunotherapy","","Recent breakthroughs in tumor immunotherapy confirm that the immune system can fight multiple cancers, but effective treatment depends on coordinated tumor cell elimination and enhanced patient immunity. Changes within the tumor immune microenvironment reshape how anti-tumor drugs work, producing either favorable or unfavorable immune outcomes through modulation of tumor-infiltrating lymphocytes. CD8+ T cells are central tumor-infiltrating effectors. This review summarizes how cancer stem cells regulate tumor development and prognosis by directly or indirectly altering the function of infiltrating CD8+ T cells and discusses related immunotherapy strategies.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/new-insights-on-anti-tumor-immunity-of-cd8-t-cells-cancer-stem-cells-tumor-immune-microenvironment-and-immunotherapy/368297/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/new-insights-on-anti-tumor-immunity-of-cd8-t-cells-cancer-stem-cells-tumor-immune-microenvironment-and-immunotherapy/368297.png","ImageObject",300,407,{"name":42,"@type":43},"Levi","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-10-30","2026-09-23",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",11,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What role do CD8+ T cells play in anti-tumor immunity?","Question",{"text":63,"@type":64},"CD8+ T cells are primary tumor-infiltrating immune cells that provide anti-tumor responses. They detect tumor (or infected) cells via TCR recognition of MHC class I peptide complexes and can kill target cells.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"How does the tumor immune microenvironment influence anti-tumor therapy outcomes?",{"text":68,"@type":64},"Dynamic changes in the tumor immune microenvironment alter the real effects of anti-tumor drugs. By modulating tumor-infiltrating lymphocytes, it can trigger favorable or unfavorable immune responses.",{"name":70,"@type":61,"acceptedAnswer":71},"How do cancer stem cells affect tumor progression and CD8+ T cell function?",{"text":72,"@type":64},"Cancer stem cells can promote tumor invasion and metastasis through mechanisms such as enhanced angiogenesis and cytokine production. They also regulate the role of tumor-infiltrating CD8+ T cells, influencing tumor development and prognosis.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},368297,1790295379,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,111,115,120,123,127],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},7,"Healthcare",40,"healthcare",{"id":112,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":113,"slug":114},8,30,"research-report",{"id":116,"doc_module":4,"doc_module_name":25,"category_name":117,"show_sort_weight":118,"slug":119},9,"Religion & Spirituality",20,"religion-spirituality",{"id":118,"doc_module":4,"doc_module_name":25,"category_name":121,"show_sort_weight":118,"slug":122},"World Cup","world-cup",{"id":124,"doc_module":4,"doc_module_name":25,"category_name":125,"show_sort_weight":124,"slug":126},10,"Lifestyle","lifestyle",{"id":128,"doc_module":4,"doc_module_name":25,"category_name":129,"show_sort_weight":97,"slug":130},19,"General","general",{"code":4,"msg":82,"data":132},{"doc_id":79,"user_id":133,"nickname":42,"user_avatar":134,"doc_module":4,"category_id":112,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":128,"language":140,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":12,"update_tm":144,"read_time":145,"preview_page_count":33,"preview_urls":146},7971461740909,"https://ap-avatar.wpscdn.com/davatar_155a257f0dc6eb9ab79c44ca47cae57d","Lin et al. Journal of Translational Medicine (2025) 23:341  \n[https://doi.org/10.1186/s12967-025-06291-y](https://doi.org/10.1186/s12967-025-06291-y)  \nJournal of Translational Medicine  \nREVIEW Open Access  \nNew insights on anti-tumor immunity of CD8+ T cells: cancer stem cells, tumor immune microenvironment and immunotherapy  \nYibin Lin 1, Yifu Song 1, Yaochuan Zhang 1, Xiaodong Li2, Liang Kan3* and Sheng Han 1*  \nAbstract  \nRecent breakthroughs in tumor immunotherapy have confirmed the capacity of the immune system to fight several cancers. The effective means of treating cancer involves accelerating the death of tumor cells and improving patient immunity. Dynamic changes in the tumor immune microenvironment alter the actual effects of anti-tumor drug production and may trigger favorable or unfavorable immune responses by modulating tumorinfiltrating lymphocytes. Notably, CD8+ T cells are one of the primary tumor-infiltrating immune cells that provide anti-tumor response. Tumor cells and tumor stem cells will resist or evade destruction through various mechanisms as CD8+ T cells exert their anti-tumor function. This paper reviews the research on the regulation of tumor development and prognosis by cancer stem cells that directly or indirectly alter the role of tumor-infiltrating CD8+ T cells. We also discuss related immunotherapy strategies.  \nKeywords Cytotoxic CD8+ T lymphocyte (CTL), Cancer stem cell (CSC), Cancer prognosis, Tumor immune microenvironment (TIME), Immunotherapy  \nIntroduction  \nThe process of tumor immunity has been extensively investigated. Specific antigens are expressed by tumor cells with oncogenic mutations to distinguish between malignant and healthy cells as well as help immune cells, e.g., antigen-presenting cells (APCs), in identifying suitable tumor antigens. APCs then present tumor antigens to T cells in the lymph nodes and activate them.  \n*Correspondence:  \nLiang Kan[kanliang31cmu@163.com](kanliang31cmu@163.com)[ ](kanliang31cmu@163.com)Sheng Han [hansheng2001_x@aliyun.com](hansheng2001_x@aliyun.com)  \n1Department of Neurosurgery, The First Hospital of China Medical University, Shenyang 110001, China  \n2Department of Neurosurgery, Siping Central People’s Hospital, Siping, Jilin 136000, China  \n3Department of Geriatrics, Shengjing Hospital of China Medical University, Shenyang 110004, China  \nActivated T cells infiltrating into the tumor detect specific antigens on cancer cells and eventually kill them. During this process, several factors in the tumor microenvironment (TME) differentially regulate the activity and functional effects of tumor-infiltrating T cells.  \nCytotoxic T cells, or CD8+ T cells detect tumor or infected cells by binding their T cell receptor (TCR), specifically to the MHC class I peptide complex. Effector CD8+ T cells develop into memory cells that halt reexposure to the antigen after clearing. Effector CD8+ T lymphocytes become depleted in circumstances when the antigen is not eliminated, i.e., during cancer or persistent infections, conditions that reduce proliferation and cytotoxicity. Inhibitory molecules like PD-1 are expressed by depleted CD8+ T cells, which increase the depletion phenotype [1]. Immune checkpoint blockade (ICB) medications reduce inhibitory signaling in depleted CD8+ T lymphocytes to restore their proliferative and  \n© The Author(s) 2025. Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended u","cbCaioVsOReaevwX","https://ap.wps.com/l/cbCaioVsOReaevwX","pdf",2583697,"English","# Introduction\n## CD8+ T cells activation and infiltration\n## CD8+ T cells function, exhaustion, and checkpoint pathways\n## Cancer stem cells (CSCs) and their regulation in the tumor microenvironment\n## CSCs impact on CD8+ T cells and implications for immunotherapy","[{\"question\":\"What role do CD8+ T cells play in anti-tumor immunity?\",\"answer\":\"CD8+ T cells are primary tumor-infiltrating immune cells that provide anti-tumor responses. They detect tumor (or infected) cells via TCR recognition of MHC class I peptide complexes and can kill target cells.\"},{\"question\":\"How does the tumor immune microenvironment influence anti-tumor therapy outcomes?\",\"answer\":\"Dynamic changes in the tumor immune microenvironment alter the real effects of anti-tumor drugs. By modulating tumor-infiltrating lymphocytes, it can trigger favorable or unfavorable immune responses.\"},{\"question\":\"How do cancer stem cells affect tumor progression and CD8+ T cell function?\",\"answer\":\"Cancer stem cells can promote tumor invasion and metastasis through mechanisms such as enhanced angiogenesis and cytokine production. They also regulate the role of tumor-infiltrating CD8+ T cells, influencing tumor development and prognosis.\"}]","New insights on anti-tumor immunity of CD8+ T cells: cancer stem cells, tumor immune microenvironment and immunotherapy | PDF",1790176114,48,[147,151,155,159],{"page_no":22,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/96fde153620778d9e570456fbc520cb6.webp",983,1310,{"page_no":26,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/834f2b203d83aca64e889212baa84895.webp",982,1309,{"page_no":30,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/5d9ebcde89d1bd9b3bcf21b114e764b6.webp",981,1308,{"page_no":33,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/7748da66a7dc562c78cce6edc82ef8fe.webp",980,1306]